Lifevantage Corporation (LFVN) PT Lowered to $5 at Lake Street Capital Markets Feb 5, 2026 08:48AM
Lifevantage (LFVN) Declares $0.045 Quarterly Dividend; 3.2% Yield Feb 4, 2026 04:06PM
Lifevantage (LFVN) Reports In-Line Q2 EPS ; Offers Guidance Feb 4, 2026 04:06PM
Stonegate Attends ICR 2026, Highlighted by Fireside Chat with Nu Skin (NUS) Jan 14, 2026 04:41PM
Lifevantage (LFVN) Misses Q1 EPS by 3c Nov 4, 2025 04:43PM


Nov 4, 2025 04:09PM Lifevantage (LFVN) Declares $0.045 Quarterly Dividend; 2.6% Yield
Oct 2, 2025 08:02AM LifeVantage completes LoveBiome acquisition for microbiome expansion
Sep 4, 2025 04:09PM Lifevantage (LFVN) Tops Q4 EPS by 1c; offers guidance
Sep 3, 2025 05:00PM LifeVantage to acquire microbiome health company LoveBiome
Aug 28, 2025 04:06PM Lifevantage (LFVN) Declares $0.045 Quarterly Dividend; 1.4% Yield
Jul 22, 2025 08:03AM LifeVantage reports clinical study shows 200% increase in GLP-1 production
May 6, 2025 05:03PM Lifevantage (LFVN) Tops Q3 EPS by 6c
May 6, 2025 04:07PM Lifevantage (LFVN) Raises Quarterly Dividend 12.5% to $0.045; 1.5% Yield
Mar 3, 2025 04:06PM Lifevantage (LFVN) Launches LV360 and Evolve Compensation Plan in Philippines, Taiwan, Hong Kong, and Singapore Markets
Feb 5, 2025 04:58PM Lifevantage (LFVN) Tops Q2 EPS by 8c, offers guidance
Feb 4, 2025 08:06AM Lifevantage (LFVN) Announces Completion of International In Vitro Study on the MB System
Jan 16, 2025 08:00AM Lifevantage (LFVN) Appoints Todd Thompson as Chief Information and Innovation Officer
Jan 14, 2025 08:45AM Craig-Hallum Starts Lifevantage Corporation (LFVN) at Buy
Jan 13, 2025 08:14AM Lifevantage (LFVN) Study Confirms Breakthrough Synergistic Effects of Healthy Weight Stack
Jan 13, 2025 08:14AM Lifevantage (LFVN) Launches 2025 Vision with “Drive ERA” Theme and International Expansion Plans for Evolve Compensation Plan and the MindBody GLP-1 System
Oct 29, 2024 04:14PM Lifevantage (LFVN) Misses Q1 EPS by 2c, provides guidance
Oct 29, 2024 04:06PM Lifevantage (LFVN) Declares $0.04 Quarterly Dividend; 1.3% Yield
Sep 26, 2024 08:02AM Lifevantage (LFVN) Completes Successful Human Clinical Trial with New GLP-1 System for Activated Weight Loss
Sep 10, 2024 08:01AM Lifevantage (LFVN) Announces Positive In Vitro Results for New GLP-1 System
Aug 28, 2024 04:08PM Lifevantage (LFVN) Misses Q4 EPS by 7c, provides guidance
Aug 28, 2024 04:07PM Lifevantage (LFVN) Declares $0.04 Quarterly Dividend; 1.8% Yield